Meeting the Needs of Study Participants During the COVID-19 Pandemic Date Published: May 05, 2020 Whitepaper In this informational white paper, Signant’s Denis Curtin shares best practices and ongoing learnings related to COVID-19. Denis details the following patient engagement features that have been used during the COVID-19 crisis: Study updates Prescreening surveys Reconsent information Appointment/visit rescheduling Retention messages Trial instructions Safety resources Online social communities Denis also argues that video capabilities are essential and can help studies overcome the COVID-19 safety concerns in such a way that prevents them from being placed on hold or discontinued. Download Now Share: LinkedInTweet Recommended Resources 3 Themes and Takeaways From FDA’s Draft Guidance on DCTs Download Now Whitepaper Computerized Adaptive Tests Using PROMIS CAT Download Now Whitepaper The EMA Recommendation Paper on Decentralized Elements in Clinical Trials: An Overview Read Our White Paper Whitepaper